Arcadia Biosciences
RKDA
11 hedge funds and large institutions have $894K invested in Arcadia Biosciences in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
0.08% less ownership
Funds ownership: 0.23% → 0.15% (-0.08%)
15% less funds holding
Funds holding: 13 → 11 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
58% less capital invested
Capital invested by funds: $2.14M → $894K (-$1.25M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$232K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$93.6K |
| 3 |
VF
Virtu Financial
New York
|
+$4.03K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$763K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$106K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$67K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$63K |
| 5 |
Morgan Stanley
New York
|
-$9.08K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $303K | -$763K | -4,542 | -65% |
|
|
AFM
2
Anson Funds Management
Dallas,
Texas
| $175K | +$232K | +1,383 | New |
|
|
3
Bank of Montreal
Toronto,
Ontario, Canada
| $127K | -$63K | -375 | -27% |
|
|
VF
4
Virtu Financial
New York
| $81K | +$4.03K | +24 | +4% |
|
5
Dimensional Fund Advisors
Austin,
Texas
| $73K | – | – | – |
|
|
OAM
6
Oxford Asset Management
Oxford,
United Kingdom
| $71K | +$93.6K | +557 | New |
|
7
Vanguard Group
Malvern,
Pennsylvania
| $59K | – | – | – |
|
|
AG
8
Advisor Group
Phoenix,
Arizona
| $3K | – | – | – |
|
9
BlackRock
New York
| $1K | – | – | – |
|
|
SWM
10
SeaCrest Wealth Management
Purchase,
New York
| $1K | – | – | – |
|
|
11
Wells Fargo
San Francisco,
California
| – | -$106K | -544 | Closed |
|
|
12
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$67K | -343 | Closed |
|
|
13
Morgan Stanley
New York
| – | -$9.08K | -54 | -98% |
|
|
VFA
14
Valeo Financial Advisors
Carmel,
Indiana
| – | -$5K | -30 | Closed |
|
RKDA Hedge Fund Activity: Q4 2018 in Review
11 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q4 2018, worth a combined $894K — down 58% from $2.14M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of RKDA and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $232K. The largest seller was Sabby Management, cutting an estimated $763K.
- 11 institutional investors held Arcadia Biosciences (RKDA) as of Q4 2018, down from 13 in Q3 2018.
- Funds reported $894K of Arcadia Biosciences stock for Q4 2018, down 58% quarter-over-quarter.
- 2 funds opened new Arcadia Biosciences positions in Q4 2018 and 4 closed out, a net change of -2 holders.
- The largest Arcadia Biosciences buyer in Q4 2018 was Anson Funds Management, an estimated $232K added.
- The largest Arcadia Biosciences seller in Q4 2018 was Sabby Management, an estimated $763K sold.
Based on aggregated 13F filings for Q4 2018.